The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas

The identification of new proliferation markers could have clinical implications in ovarian carcinoma by stratifying patients for treatment and follow-up. The aim of this study was to evaluate the diagnostic and prognostic value of the proliferation markers Ki-67/MIB-1, phosphorylated histone H3 (PH...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Aune, Guro, Stunes, Astrid K, Tingulstad, Solveig, Salvesen, Øyvind, Syversen, Unni, Torp, Sverre H
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3127066/
https://ncbi.nlm.nih.gov/pubmed/21738816
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars